CXCL8 and skin squamous cell carcinoma: Subsequent studies revealed that the expression of IL-1β and IL-8 factors was reduced in responders, providing substantial evidence for their utilization as emerging biomarkers for evaluating the efficacy of anti-PD-1 therapy in cSCC patients (67).